Paris-based medical device maker Carmat this month successfully implanted its 1st bioprosthetic artificial heart, according to a company statement.
The company conducted the implant as part of a feasibility study, in accord with approval studies with the French health authority, the ANSM.
The operation was conducted in Paris at Georges Pompidou European Hospital. The patient remained under monitoring, but the heart was providing normal blood flow at a normal rate, according to a press release.
“We are delighted with this 1st implant, although it is obviously far too early to draw conclusions given that this is the 1st such implant and surgery has only just been performed,” CEO Marcello Conviti said in prepared remarks.